Music Therapy for Neonatal Abstinence Syndrome

Tulane Lakeside Hospital - Tulane University, Metairie, LA
Neonatal Abstinence Syndrome+1 More ConditionsMusic Therapy - Other
Eligibility
1 - 1
All Sexes
What conditions do you have?
Select

Study Summary

This trial is looking at whether music therapy can help newborns with opioid withdrawal syndrome by reducing symptoms and resource use.

Eligible Conditions
  • Neonatal Abstinence Syndrome
  • Neonatal Substance Withdrawal

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Study Objectives

6 Primary · 0 Secondary · Reporting Duration: Change in phase of sleep over the 20 minute sessions (both control and music therapy)

Change in average heart rate over the 20 minute sessions (both control and music therapy)
Change in Heart Rate
Change in average heart rate variability over the 20 minute sessions (both control and music therapy)
Change in Heart Rate Variability
Change in phase of sleep over the 20 minute sessions (both control and music therapy)
Change in Sleeping Patterns
Month 6
Morphine Utilization
Total Length of Stay
Time from feeding to onset of sleep over the 20 minute session (both control and music therapy)
Change in Feeding Patterns

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Control
1 of 2
Music Therapy
1 of 2

Active Control

Experimental Treatment

300 Total Participants · 2 Treatment Groups

Primary Treatment: Music Therapy · No Placebo Group · N/A

Music Therapy
Other
Experimental Group · 1 Intervention: Music Therapy · Intervention Types: Other
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: change in phase of sleep over the 20 minute sessions (both control and music therapy)

Who is running the clinical trial?

Tulane UniversityLead Sponsor
99 Previous Clinical Trials
215,582 Total Patients Enrolled
Meghan P Howell, MDPrincipal InvestigatorTulane University

Eligibility Criteria

Age 1 - 1 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You were not born with Fetal Alcohol Syndrome.
You do not have a known developmental disability like Down Syndrome.

Frequently Asked Questions

What criteria must a person meet to be included in this clinical trial?

"This medical investigation is enrolling 300 infants aged 1 minute to one month with passive addiction. In order to participate, they must have been admitted in a NICU or newborn nursery, have a corrected gestational age of 34 weeks or more, not suffer from any hearing disorders, no diagnosed developmental disability (such as Down Syndrome) and their parent/legal guardian must be willing to consent and complete surveys." - Anonymous Online Contributor

Unverified Answer

Does this experiment currently accept new participants?

"Affirmative. According to clinicaltrials.gov, this medical investigation commenced on December 10th 2018 and is currently recruiting participants. 300 individuals must be enrolled from a single site of the study." - Anonymous Online Contributor

Unverified Answer

What is the current enrollment capacity for this clinical investigation?

"Affirmative. According to clinicaltrials.gov, the trial that was initially posted on December 10th 2018 is still recruiting volunteers. 300 prospective participants are needed from a single medical site for this experiment." - Anonymous Online Contributor

Unverified Answer

Are individuals over 45 years of age eligible to participate in this research?

"This trial is including individuals between 1 year and 1 month old." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.